NOVUMWORLD | 🤖
  • EN
  • ES
SECCIONES
  • AI & SaaS
  • Crypto
  • Biohacking
  • Creators
  • Viral
  • Tools
  • Funds
  • About Us
  • Privacy Policy
  • Terms of Service
  • Contact

© 2026 NOVUMWORLD. INDEPENDENT UNFILTERED JOURNALISM.

FUNDS INTELLIGENCE

Investment Funds & Stocks

Professional analysis of investment funds, ETFs, and financial markets. Performance comparisons, fees, and expert reviews.

Roundhill Sports Betting ETF Shifts to Active Management, Aiming for 20% Better Returns
FUNDS Jun 16, 2026

Roundhill Sports Betting ETF Shifts to Active Management, Aiming for 20% Better Returns

Discover how Roundhill Sports Betting ETF's shift to active management aims to enhance returns by 20%. Explore strategies and …
✍️ NovumWorld Editorial Team
Read More
Amundi, CACEIS, and Ant International Forge Blockchain Solutions for Enhanced Treasury Management
FUNDS Jun 15, 2026

Amundi, CACEIS, and Ant International Forge Blockchain Solutions for Enhanced Treasury Management

Discover how Amundi, CACEIS, and Ant International are leveraging blockchain technology to revolutionize treasury management in …
✍️ NovumWorld Editorial Team
Read More
Amundi and CACEIS Collaborate with Ant International for 2023 Blockchain Treasury Solutions
FUNDS Jun 15, 2026

Amundi and CACEIS Collaborate with Ant International for 2023 Blockchain Treasury Solutions

Discover how Amundi and CACEIS are partnering with Ant International to revolutionize blockchain treasury solutions in 2023. …
✍️ NovumWorld Editorial Team
Read More
Kos Biotechnology Partners Secures $123 Million in Third Closing of Life Sciences Fund
FUNDS Jun 14, 2026

Kos Biotechnology Partners Secures $123 Million in Third Closing of Life Sciences Fund

Kos Biotechnology Partners raises $123 million in its third closing of a life sciences fund, boosting investment in innovative …
✍️ NovumWorld Editorial Team
Read More
Kos Biotechnology Partners Secures $123 Million in Global Life Sciences Fund Closing
FUNDS Jun 14, 2026

Kos Biotechnology Partners Secures $123 Million in Global Life Sciences Fund Closing

Kos Biotechnology Partners has raised $123 million in its latest global life sciences fund, paving the way for innovative health …
✍️ NovumWorld Editorial Team
Read More
Morningstar’s CME Derivatives Deal Boosts MORN’s Investment Story by 25%
FUNDS Jun 13, 2026

Morningstar’s CME Derivatives Deal Boosts MORN’s Investment Story by 25%

Discover how Morningstar's CME derivatives deal enhances MORN's investment narrative, driving a remarkable 25% growth in value and …
✍️ NovumWorld Editorial Team
Read More
  • ««
  • «
  • 2
  • 3
  • 4
  • 5
  • 6
  • »
  • »»
NOVUMWORLD

Autonomous Data Journalism & AI Signals Platform

Systems Operational 100%
About Us Contact Privacy Policy Terms of Service
© 2026 NovumWorld. All rights reserved.